The elk prion protein gene (PRNP) encodes either methionine (M) or leucine (L) at codon 132, the L132 allele apparently affording protection against chronic wasting disease (CWD). The corresponding human codon 129 polymorphism influences the host range of bovine spongiform encephalopathy (BSE) prions. To fully address the influence of this cervid polymorphism on CWD pathogenesis, we created transgenic (Tg) mice expressing cervid PrP C with L at residue 132, referred to as CerPrP C -L132, and compared the transmissibility of CWD prions from elk of defined PRNP genotypes, namely homozygous M/M or L/L or heterozygous M/L, in these Tg mice with previously described Tg mice expressing CerPrP C -M132, referred to as Tg(CerPrP) mice. While Tg(CerPrP) mice were consistently susceptible to CWD prions from elk of all three genotypes, Tg(CerPrP-L132) mice uniformly failed to develop disease following challenge with CWD prions. In contrast, SSBP/1 sheep scrapie prions transmitted efficiently to both Tg(CerPrP) and Tg(CerPrP-L132) mice. Our findings suggest that the elk 132 polymorphism controls prion susceptibility at the level of prion strain selection and that cervid PrP L132 severely restricts propagation of CWD prions. We speculate that the L132 polymorphism results in less efficient conversion of CerPrP C -L132 by CWD prions, an effect that is overcome by the SSBP/1 strain. Our studies show the accumulation of subclinical levels of CerPrP Sc in aged asymptomatic CWD-inoculated Tg(CerPrP-L132) mice and also suggests the establishment of a latent infection state in apparently healthy elk expressing this seemingly protective allele.
INTRODUCTION
The transmissible spongiform encephalopathies, a group of fatal incurable neurodegenerative conditions, include sheep scrapie, bovine spongiform encephalopathy (BSE), chronic wasting disease (CWD) of deer and elk, and human Creutzfeldt-Jakob disease (CJD). The prevailing viewpoint attributes these disorders to prions, defined as subcellular proteinaceous infectious particles that lack informational nucleic acid (Prusiner, 1982) . Considerable evidence now supports the once unorthodox hypothesis that prions are composed largely, if not entirely, of a pathogenic conformer of the prion protein (PrP), referred to as PrP Sc , which, during disease, imposes its conformation on the normal hostencoded version of PrP, referred to as PrP Prion diseases frequently occur as epidemics and their capacity to transmit between species is unpredictable. Of particular concern is the emergence of CWD, the only recognized prion disease of wild animals (Williams, 2005) . In addition to its distribution in an increasingly wide geographical area of North America, outbreaks in South Korea resulted from importation of subclinically infected animals (Kim et al., 2005; Sohn et al., 2002) . Its enigmatic origins, contagious transmission, uncertain strain prevalence and environmental persistence raise the possibility of uncontrolled prion dissemination and bring into question the risk to other species of developing a CWD-related disease.
Seminal studies in transgenic (Tg) mice (Prusiner et al., 1990; Scott et al., 1993) and cell-free systems (Kocisko et al., 1994) suggested that the sequences of PrP Sc in the inoculum and PrP C in the host should be isologous for optimal progression of disease. However, the rules governing PrP primary structure control over prion transmission appear not to apply in the case of bank voles, which are susceptible to prions from a number of different mammalian species (Nonno et al., 2006) . Prion strain properties are an equally important consideration. Mammalian prion strains are classically defined by their incubation times in susceptible animals and the profile of central nervous system (CNS) lesions. Since numerous studies indicate that strain diversity is encoded in the tertiary structure of PrP Sc (Bessen & Marsh, 1994; Korth et al., 2003; Peretz et al., 2002; Scott et al., 2005; Telling et al., 1996) , assessment of different PrP Sc types according to the Western blot migration patterns of protease-resistant PrP Sc glycoforms, the conformational stability of PrP Sc and the neuroanatomic distribution of PrP Sc are parameters that have also been used to characterize prion strains (Collinge et al., 1996b; Hecker et al., 1992; Hill et al., 1997; Peretz et al., 2002; Safar et al., 1998; Taraboulos et al., 1992) . The unexpectedly wide host range of BSE prions illustrates the capacity of prion strains to cross species barriers and overcome the influence of PrP primary structure.
PrP polymorphisms influence prion pathogenesis in mice (Westaway et al., 1987) , sheep (Hunter et al., 2000) and humans (Baker et al., 1991; Collinge et al., 1991; Palmer et al., 1991) . The PRNP-coding sequence of elk is polymorphic at codon 132 encoding either methionine (M) or leucine (L) (O'Rourke et al., 1998; Schatzl et al., 1997) . Residue 132 in elk is equivalent to the human PRNP codon M129 or valine (V) polymorphism, which is an important factor in sporadic, iatrogenic and familial human prion diseases (Baker et al., 1991; Collinge et al., 1991; Palmer et al., 1991) and plays an important role in controlling the propagation of human prion strains (Collinge et al., 1996b; Wadsworth et al., 1999) . To date, all clinical cases of vCJD have only occurred in patients homozygous for M at codon 129 (Collinge et al., 1996a; Zeidler et al., 1997) and analyses in Tg mice confirmed that V129 protects against the development of vCJD (Wadsworth et al., 2004) . Since oral transmission experiments in elk suggest that the 132 L allele may protect against CWD (Hamir et al., 2006) , and because of the relationship between the cervid codon 132 and the human codon 129 polymorphism, we produced Tg mice expressing cervid PrP (CerPrP) with L at residue 132, referred to as Tg(CerPrP-L132) mice, to address the mechanism by which this polymorphism affects prion pathogenesis.
METHODS
Production and characterization of Tg mice. Tg(CerPrP)1536 and Tg(CerPrP)1534 have been described previously (Browning et al., 2004 . To produce Tg mice expressing the L132 polymorphism, referred to as CerPrP-L132, we mutated residue 132 in the CerPrP-coding sequence, originally derived from mule deer PRNP (Browning et al., 2004) by PCRinduced oligonucleotide-mismatch mutagenesis. Prior to cloning into the cosSHa.Tet cosmid , the CerPrP-L132-coding sequence was verified. Transgene purification, Tg mouse production using FVB/Prnp 0/0 mice (Lledo et al., 1996) and genotyping of Tg mice was accomplished using previously published methods (Browning et al., 2004) . Estimates of the relative levels of PrP expression in the CNS of F 1 offspring compared to the level of PrP in brain extracts from wild-type mice were determined by Western blotting and quantitative immuno-dot blotting by using anti-PrP 6H4 monoclonal antibody (mAb) (Korth et al., 1997) (Prionics AG). Immunoblots were developed using enhanced chemiluminescence (ECL), and exposed to X-ray film or analysed using a FLA-5000 scanner (Fuji). Tg(CerPrP-L132) lines were also maintained in the hemizygous state by breeding with Prnp 0/0 mice.
Sources and preparation of brain homogenates. The naturally infected captive mule deer isolates D10 and Db99, the 7378 elk isolate and the CWD pool have been described previously (Browning et al., 2004) . (Dickinson et al., 1989) . Homogenates (10 %, w/v) in PBS lacking calcium and magnesium ions, of cervid, sheep and mouse brain homogenates, were prepared by repeated extrusion through an 18-gauge followed by a 21-gauge syringe needle.
Determination of incubation periods. Groups of anaesthetized mice were inoculated intracerebrally with 30 ml 1 % brain extracts prepared in PBS. Inoculated mice were diagnosed with prion disease following the progressive development of at least three signs including truncal ataxia, 'plastic' tail, loss of extensor reflex, difficultly righting and slowed movement. The time from inoculation to the onset of clinical signs is referred to as the incubation period.
Analysis of PrP in CNS. For PrP analysis in brain extracts, total protein content from 10 % brain homogenates prepared in PBS was determined by bicinchoninic acid assay (Pierce Biotechnology). Brain extracts were either untreated or treated with 40 mg proteinase K (PK) ml 21 for 1 h at 37 uC in the presence of 2 % Sarkosyl and the reaction was terminated with 4 mM PMSF. Proteins were separated by SDS-PAGE, electrophoretically transferred to PVDF-FL membranes (Millipore) that were probed with mAb 6H4 or the Hum-P antiPrP recombinant Fab (Safar et al., 2002) followed by horseradish peroxidase-conjugated sheep anti-mouse IgG or goat anti-human secondary antibody, respectively, developed using ECL-plus detection (Amersham), and analysed using a FLA-5000 scanner (Fuji). In some cases mice exhibiting neurological dysfunction were humanely killed and their brains were immediately frozen on dry ice. Histoblots of 10 mm thick cryostat sections were generated and transferred to nitrocellulose as described previously . Histoblots were immunostained with the Hum-P anti-PrP recombinant Fab followed by alkaline phosphatase-conjugated goat anti-human secondary antibody. PrP Sc in brain homogenates of terminally sick mice was also analysed by a modified conformational stability assay (Peretz et al., 2002; Scott et al., 2005) . Analysis of PrP in the brains of Tg mice by immunohistochemistry was performed as described previously (Muramoto et al., 1997) by using anti-PrP mAb 6H4 as the primary antibody and IgG 1 biotinylated goat anti-mouse as the secondary antibody (Southern Biotech). Digitized images for figures were obtained by using a Nikon Eclipse E600 microscope equipped with a Nikon DMX 1200F digital camera, and Metamorph software to view and photograph slides.
RESULTS
CWD prions fail to induce disease in Tg(CerPrP-L132) mice
We have previously shown that prion transmission from CWD-affected deer and elk to Tg(CerPrP)1536 +/2 and Tg(CerPrP)1534 +/2 mice was characterized by 100 % attack rates and mean incubation times ranging from~225 to 270 days (Browning et al., 2004) (Table 1) , after which time asymptomatic-inoculated mice were humanely killed.
Any comparison between the susceptibility of Tg(CerPrP) and Tg(CerPrP-L132) mice must take into account the level of transgene expression. Generally, the level of transgene expression is inversely related to the length of the incubation time (Prusiner et al., 1990) . The level of expression in Tg(CerPrP-L132)1970
and Tg(CerPrP-L132)1973 +/2 mice was approximately fourfold higher than the level of PrP C in the brains of wild-type FVB mice, while levels of expression in Tg(CerPrP)1536
and Tg(CerPrP)1534 +/2 mice were previously estimated to be approximately five-and threefold higher (Browning et al., 2004) . Examples of PrP C expression in Tg(CerPrP)1536
and Tg(CerPrP-L132)1973
mice are shown in Supplementary Fig. S1 (a) (available in JGV Online). Since Tg(CerPrP-L132)1973 +/2 and Tg(CerPrP-L132)1970 
The number of mice developing prion disease divided by the original number of inoculated mice is shown in parentheses.
DPreviously reported (Browning et al., 2004) . dBrain homogenate. §Prion disease could only be confirmed in the number of animals represented by the numerator because of intercurrent illnesses in aged mice, which necessitated that mice be humanely euthanized. These illnesses included lung infection and serious dermatitis. In one case an animal was found dead, the animal being apparently cannibalized by cage mate(s). In no case did any intercurrent disease appear to be related to the overexpression of prion protein in Tg(CerPrP)1536 +/2 mice.
||Retropharangeal lymph node homogenate.
mice express transgene-encoded PrP at levels in the same range as Tg(CerPrP)1534 +/2 and Tg(CerPrP)1536
, and all mice are syngeneic except for the codon 132 polymorphism, we conclude that the differences in susceptibility between the Tg(CerPrP) and Tg(CerPrP-L132) lines are most likely the effect of the 132 polymorphism.
The resistance of animals expressing CerPrP C -L132 to CWD is not due to amino acid mismatches at residue 132 DNA sequence analysis of PRNP alleles confirmed that the D10, Db99 and 7378 isolates were from cervids that were homozygous M/M at codon 132 ( and Tg(CerPrP-L132)1973 +/2 mice inoculated with SSBP/1 scrapie prions (Fig. 2) with a subtle, but discernible shift in the molecular mass of PrP27-30 registered on adaptation of SSBP/1 prions in Tg(CerPrP-L132)1973 +/2 mice.
The ability of prions to overcome the inhibitory effects of the CerPrP-L132 allele are strain dependent
The close association of codon 129 genotypes and PrP Sc types in previous studies indicated that polymorphism at codon 129 plays an important role in the propagation of human prion strains (Collinge et al., 1996b; Wadsworth et al., 1999) . We therefore measured various strain-related parameters to ascertain whether the differential suscep tibilities of Tg(CerPrP)1536 +/2 and Tg(CerPrP-L132)1973 +/2 mice to CWD and SSBP/1 scrapie prions correlated with differences in the strain properties of those prions.
Since previous studies showed the unfolding characteristics of PrP Sc to be a sensitive and quantitative means of assessing strain-dependent differences in PrP Sc conformation (Peretz et al., 2002; Scott et al., 2005) , we measured the conformational stability of CerPrP Sc in brain extracts of sick Tg(CerPrP)1536 +/2 mice inoculated with CWD or SSBP/1 prions by denaturation with increasing concentrations of guanidine hydrochloride (GdnHCl), followed by PK digestion and immunodetection of residual CerPrP Sc . When plotted, the data points, representing the mean values derived from analysis of PrP in three or four mouse brain extracts in each case, formed sigmoidal curves with one major transition occurring at the concentration at which half of CerPrP Sc in the samples was denatured, referred to as the mean GdnHCl 1/2 value. The mean GdnHCl 1/2 values of CerPrP Sc produced in the brains of Tg(CerPrP)1536 +/2 mice infected with CWD prions from the 132 M/M, 132 M/L and 132 L/L elk isolates ranged from 2.35 to 2.71, reflecting high conformational stabilities in each case (Fig. 3a) . Interestingly, the stability of CerPrP Sc -L132 produced in the brains of asymptomatic Tg(CerPrP-L132)1973 +/2 mice inoculated with CWD prions from the 132 M/M elk isolate was lower than 
CerPrP
Sc -M132 produced in the brains of diseased Tg(CerPrP)1536 +/2 mice inoculated with the same prions (Fig. 3a) . Additional transmission experiments are in progress to ascertain whether passage of this isolate in Tg(CerPrP-L132)1973 +/2 mice results in a stable adaptation of the strain properties of these CWD prions. The lower mean GdnHCl 1/2 values of CerPrP Sc produced in the brains of Tg(CerPrP)1536 +/2 and Tg(CerPrP-L132)1973 +/2 mice infected with SSBP/1 prions, as well as the different denaturation profiles, indicated that the stabilities of these CerPrP Sc species were similar to each other but lower than the stabilities of CerPrP Sc species produced in the brains of Tg(CerPrP)1536 +/2 mice infected with CWD prions (Fig. 3b) .
Variation in the extent of PrP
Sc glycosylation is another parameter that has been used to characterize prion strains (Collinge et al., 1996b; Hill et al., 1997) . We therefore assessed the extent of PrP (Fig. 4) Sc glycosylation but that these differences are primarily the result of the host rather than the agent strain effects.
Histoblot analysis ) is a useful tool for assessing strain-related differences in the global distribution of PrP Sc (DeArmond et al., 1993; Hecker et al., 1992; Mastrianni et al., 1999; Telling et al., 1996) . Histoblot patterns of PrP in the brains of SSBP/1-infected Tg(CerPrP)1536 +/2 and Tg(CerPrP-L132)1973 +/2 mice showed widespread and diffuse distribution of CerPrP Sc (Fig. 5) . The most intense PrP Sc signals occurred primarily in sites largely devoid of PrP C , a phenomenon detailed in the seminal studies of Taraboulos et al. (1992) and subsequently confirmed in studies of scrapie-infected mice (Yokoyama et al., 2001) , and in the brains of BSE-or scrapie-affected cattle and sheep (Kimura et al., 2002) . While patterns of immunostaining were not identical among histoblots of Tg(CerPrP)1536 +/2 mice infected with CWD prions from the 132 M/M, 132 M/L and 132 L/L elk isolates, or compared to previously described Tg(CerPrP)1536 +/2 mice infected with elk or mule deer CWD prions (Browning et al., 2004) , widespread punctate deposition of CerPrP Sc -M132 was a consistent feature, which contrasted sharply with the diffuse distribution of CerPrP Sc in Tg mice infected with SSBP/1 prions (Fig. 5) . Punctate staining, which was not present in uninfected Tg mice [ Supplementary Fig. S1 (b-e) available in JGV Online] or in Tg mice infected with SSBP/1 prions (Fig. 5) , was seen to greatest effect in the absence of PK treatment, suggesting that a subset of CerPrP Sc in these deposits was protease sensitive.
We performed immunohistochemistry to precisely characterize the PrP immunostaining in the brains of CWD-infected Tg(CerPrP)1536) +/2 mice. While plaque deposition, particularly in the hippocampus, was a neuropathologic feature of diseased Tg(CerPrP)1536 +/2 mice infected with CWD prions from 132 M/M, 132 M/L and 132 L/L elk isolates (Fig. 6 ), there were differences in the patterns of PrP immunostaining in all three cases. In Tg mice infected with the 132 M/M and 132 M/L isolates ( Fig. 6a and b) , plaques were compact and densely stained. Consistent with the histoblot pattern of immunostaining, the corpus callosum, was particularly affected, especially Strain-dependent protection by a PrP polymorphism in the case of Tg mice infected with the 132 M/M isolate (Fig. 6a) . In contrast, PrP immunostaining in Tg(CerPrP)1536 +/2 mice infected with the 132 L/L isolate was more diffuse, plaques displayed a less regular shape, and were devoid of a central dense core (Fig. 6c) .
DISCUSSION
Since our seminal reports of accelerated CWD prion transmission from deer and elk to Tg(CerPrP) mice (Browning et al., 2004) , several other groups have reported similar results using comparable Tg mouse models (Kong et al., 2005; LaFauci et al., 2006; Meade-White et al., 2007; Tamguney et al., 2006; Trifilo et al., 2007) . In the current study, we used Tg(CerPrP) mice and created Tg(CerPrP-L132) mice to investigate the effects of the elk codon 132 M/L polymorphism on CWD pathogenesis. While Tg (CerPrP) +/2 mice fail to develop disease following challenge with CWD prions. While two Tg(CerPrP-L132) lines were resistant to CWD prions from elk of all three codon 132 genotypes, the susceptibility of Tg(CerPrP-L132)1973 +/2 mice to SSBP/1 prions showed that their resistance to CWD prions was not due to a non-specific deficit in prion replication. We conclude that the differences in susceptibility between Tg(CerPrP) and Tg(CerPrP-L132) mice are most likely the effect of the 132 polymorphism. While our results are consistent with oral transmission experiments of CWD prions in elk of various codon 132 genotypes, which suggested that the L132 allele may protect against CWD (Hamir et al., 2006) , our studies provide some insight into the mechanistic basis of this protection.
Since disease transmission of CWD only occurred in Tg(CerPrP) mice expressing CerPrP C -M132, we reasoned that the resistance of Tg(CerPrP-L132) mice might be the direct result of amino acid mismatches at residue 132 between CerPrP Sc -M132 in the inocula and CerPrP C -L132 expressed in the recipient, with this residue occurring at an interface of PrP that directly affects the efficiency of PrP Sc -PrP C interactions and/or PrP C to PrP Sc conversion. Such a mechanism was proposed to explain the increased frequency of sporadic CJD in patients that are homozygous for M or V at position 129 . Studies of Tg(HuPrP) mice expressing M or V at the polymorphic codon 129 also demonstrated the influence of this residue on CJD prion propagation, with incubation times being substantially shortened when the 129 residue was the same in PrP Sc of the inoculum and PrP C of the recipient (Asante et al., 2002; Collinge et al., 1995; Hill et al., 1997; Korth et al., 2003; Telling et al., 1995) . The ability to assess the transmission characteristics of CWD prions from elk of defined PRNP genotypes allowed us to address this hypothesis directly. mice was comparable to that of naturally occurring CWD prions from M/M deer and elk (Tables 1 and 2 ). Transmission of SSBP/1 prions allowed us to isolate and characterize novel 'cervid' prions with strain properties that were distinct from naturally occurring CWD isolates, and to further investigate the effects of the codon 132 polymorphism on the efficiency of replication of this strain. While the shorter incubation times on serial passage of SSBP/1-derived prions in Tg(CerPrP)1536 +/2 and Tg(CerPrP-L132)1973 +/2 mice indicated that transmission was more efficient during isologous conversion of CerPrP C by CerPrP Sc , the ready transmission of SSBP/1-derived prions comprised of either CerPrP Sc -M132 or CerPrP Sc -L132 to either line of Tg mice confirmed that the effects of the codon 132 polymorphism on SSBP/1-derived prion transmission were minimal.
The strain properties of SSBP/1-derived prions in Tg(CerPrP)1536 +/2 mice, assessed by a number of criteria, including the neuroanatomical distribution and conformational stability profiles of CerPrP Sc , were different from those of naturally occurring CWD prion isolates. Our findings therefore suggest that the elk 132 polymorphism controls prion susceptibility at the level of prion strain selection. The contrasting ability of CWD and SSBP/1 prions to overcome the inhibitory effects of the CerPrP-L132 allele is reminiscent of the results of studies detailing the effects of the human codon 129 M/V polymorphism on vCJD/BSE prions in Tg mice, which concluded that human PrP V129 severely restricts propagation of the BSE prion strain (Wadsworth et al., 2004) . Our finding that the L132 polymorphism severely restricts propagation of CWD prions is consistent with this interpretation and we speculate that the L132 polymorphism results in less efficient conversion of CerPrP C -L132 by CWD prions, an effect that is overcome by the SSBP/1 strain. Consistent with this interpretation differences in the efficiencies of transmission of CWD prions from 132 M/M, 132 M/L and 132 L/L elk to susceptible Tg(CerPrP)1536 +/2 mice, as well as the accumulation of low levels of CerPrP Sc -L132 in the brains of asymptomatic Tg(CerPrP-L132)1973 +/2 mice inoculated with CWD prions from M/M elk, appear to be a reflection of differences in CWD prion titres in these various genetic backgrounds. Since the protective effects of the L132 allele against CWD prions are not absolute, our findings suggest that breeding strategies designed to eliminate the more susceptible elk polymorph- Recently, Meade-White et al., (2007) demonstrated resistance to CWD in Tg mice expressing serine (S) at residue 96, a naturally occurring allelic variant of white-tailed deer. In contrast to our findings, which indicate that a subclinical carrier state for CWD prion infection may be established in animals expressing CerPrP C -L132, the resistance of Tg mice expressing CerPrP-S96 appeared to be absolute (MeadeWhite et al., 2007) . Interestingly, however, CWD-affected deer homozygous for the S96 allele have been identified (Johnson et al., 2006; O'Rourke et al., 2004) , demonstrating that the S96 allele is not absolutely protective against CWD in deer. Unfortunately, only pools of CWD brain materials were available for studies in Tg mice expressing CerPrP-S96 and it was not possible to genotype the brains of the whitetailed deer used in that inoculum pool. While the results of both studies demonstrate the importance of deer PrP polymorphisms in susceptibility to CWD infection, the ability to assess the strain properties of scrapie prions and CWD isolates from elk of defined genotypes provides important information about the influence of the 132 polymorphism on prion strain selection and demonstrates that the protective effects of cervid PRNP polymorphisms are highly strain dependent.
